Suppr超能文献

维生素D补充剂价格随时间的差异:一项针对开处方者的教育倡议。

Price Dispersion of Vitamin D Supplements Over Time: An Initiative for Prescriber Education.

作者信息

Chugh Preeta K, Dabas Aashima

机构信息

Department of Pharmacology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.

Department of Paediatrics, Maulana Azad Medical College and Associated of L.N. Hospital, New Delhi, India.

出版信息

Indian J Endocrinol Metab. 2021 Mar-Apr;25(2):142-147. doi: 10.4103/ijem.ijem_159_21. Epub 2021 Sep 8.

Abstract

OBJECTIVES

High prevalence of vitamin D deficiency mandates prescribing an appropriate form of vitamin D that allows attainment of sufficiency in a cost-effective manner. We aimed to compare vitamin D products in Indian market in terms of composition and cost in 2020 with 2013 to understand price dispersion over 7 years.

METHODS

Constituents, formulations, and prices of 'branded' and generic vitamin D products were sourced from various drug information compendia and online sources. Price per defined daily dose (DDD), percentage cost variation, and change in prices over 7 years (2020 vs. 2013) was determined.

RESULTS

There has been a disproportionate increase in the number of brands and cost variation of cholecalciferol and calcitriol in the last 7 years. The percentage cost variation increased almost 10 times for calcitriol and 4.4 times for alfacalcidiol tablets and cholecalciferol granules. An analysis of >1,100 products in 2020 showed that the predominant form was calcitriol which was combined with calcium in >90% of the products with huge cost variation (>3000%). Ergocalciferol and cholecalciferol were available in 22 and 15 different strengths respectively. Median price/unit of cholecalciferol (60,000IU) was lower for tablets/capsules compared to other formulations; but with >1000% cost variation.

CONCLUSION

A wide cost variation exists with the use of different vitamin D brands and preparations with conventional cholecalciferol tablets and capsules being a low-priced alternative. Quality control measures and strict enforcements of existing regulations are essential to ensure that competitive prices of branded generics are translated into availability and affordability for the population.

摘要

目的

维生素D缺乏的高患病率要求开具合适形式的维生素D,以便以具有成本效益的方式实现充足水平。我们旨在比较2020年与2013年印度市场上维生素D产品的成分和成本,以了解7年间的价格差异。

方法

“品牌”和普通维生素D产品的成分、剂型和价格来自各种药品信息汇编和在线资源。确定每定义日剂量(DDD)的价格、成本变化百分比以及7年(2020年与2013年)内的价格变化。

结果

在过去7年中,胆钙化醇和骨化三醇的品牌数量和成本差异出现了不成比例的增加。骨化三醇的成本变化百分比增加了近10倍,阿法骨化醇片和胆钙化醇颗粒增加了4.4倍。2020年对1100多种产品的分析表明,主要形式是骨化三醇,90%以上的产品将其与钙结合,成本差异巨大(>3000%)。麦角钙化醇和胆钙化醇分别有22种和15种不同规格。与其他剂型相比,胆钙化醇(60,000IU)片剂/胶囊的单位中位价格较低;但成本差异>1000%。

结论

使用不同品牌和制剂的维生素D存在很大的成本差异,传统胆钙化醇片剂和胶囊是低价选择。质量控制措施和严格执行现有法规对于确保品牌仿制药的有竞争力价格转化为民众可获得和可承受的药品至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39bd/8477736/4ae8e41614c7/IJEM-25-142-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验